
NIR-PAT² uses an antibody linked to a light-sensitive dye to find and bind only to P. gingivalis, the key bacterium that drives gum disease, and destroys it when exposed to near-infrared light. This targeted attack removes the harmful bacterium while leaving good bacteria untouched, helping restore a healthy balance in the oral microbiome.
Image Credit: Kazuhide Sato et al., Journal of Translational Medicine, 2026. Volume 24, Journal of Translational Medicine
(CC BY-NC-ND 4.0)
Scientific Frontline: Extended "At a Glance" Summary: Near-Infrared Photo-Antibacterial Targeting Therapy (NIR-PAT²)
The Core Concept: Near-infrared photo-antibacterial targeting therapy (NIR-PAT²) is an innovative treatment for periodontitis that selectively eliminates the keystone pathogen, Porphyromonas gingivalis, while preserving the beneficial oral microbes essential for a healthy microbiome.
Key Distinction/Mechanism: Standard antibiotics and antimicrobial photodynamic therapy (aPDT) destroy both harmful and beneficial bacteria, often releasing inflammatory endotoxins. In contrast, NIR-PAT² uses a highly specific antibody-dye compound that binds only to Porphyromonas gingivalis. When exposed to near-infrared light, the dye disrupts the bacterium's outer membrane without destroying its overall structure, leaving surrounding human cells and healthy bacteria completely unharmed.
Major Frameworks/Components:
- Near-Infrared Activation: Utilizes a light-sensitive dye that accumulates on the target pathogen and creates precise membrane holes upon light exposure.
- IgY Antibodies: Employs target-specific antibodies derived from the egg yolks of immunized hens, providing a low-cost, highly scalable targeting mechanism.
- Microbiome Preservation: Selectively protects symbiotic bacterial populations, such as Streptococcus, to maintain optimal oral homeostasis.

.png)



.png)









.png)


